Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.67M Sell
20,700
-100
-0.5% -$32.7K 0.11% 145
2024
Q2
$6.5M Sell
20,800
-600
-3% -$176K 0.13% 111
2024
Q1
$5.8M Buy
+21,400
New +$6.26M 0.14% 116
2023
Q4
Hold
0
23
2023
Q3
Hold
0
21
2023
Q2
Hold
0
19
2023
Q1
Hold
0
20
2022
Q4
Hold
0
21
2022
Q3
Hold
0
55
2022
Q2
Hold
0
51
2022
Q1
Hold
0
49
2021
Q4
Hold
0
53
2021
Q3
Hold
0
46
2021
Q2
Hold
0
42
2021
Q1
Hold
0
48
2020
Q4
Hold
0
28
2020
Q3
Hold
0
29
2020
Q2
Hold
0
27
2020
Q1
Hold
0
123
2019
Q4
Hold
0
92
2019
Q3
Hold
0
54
2017
Q4
Hold
0
-$52K 40
2017
Q3
Hold
0
205
2017
Q2
Hold
0
310
2017
Q1
Hold
0
167

Other funds holding AMGN

SpiderRock Advisors's AMGN Position: Q3 2024 in Review

SpiderRock Advisors reduced its Amgen (AMGN) stake by 4.1% in Q3 2024, selling an estimated $1.09M and leaving 78,296 shares worth $25.2M. The position accounts for 0.4% of the portfolio, ranked #42.

SpiderRock Advisors first reported a position in AMGN in Q1 2024 and has held it in 3 quarters since. The position peaked at $25.5M in Q2 2024. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • SpiderRock Advisors held 78,296 shares of Amgen worth $25.2M as of Q3 2024.
  • SpiderRock Advisors sold 3,327 Amgen shares in Q3 2024, an estimated $1.09M.
  • Amgen made up 0.4% of SpiderRock Advisors's portfolio in Q3 2024, its #42 holding.
  • SpiderRock Advisors first reported a position in Amgen in Q1 2024 and has held it in 3 quarters since.
  • SpiderRock Advisors's Amgen position peaked at $25.5M in Q2 2024.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.